Back to Search Start Over

Total and high-molecular weight adiponectin and risk of colorectal cancer: the European Prospective Investigation into Cancer and Nutrition Study.

Authors :
Aleksandrova K
Boeing H
Jenab M
Bueno-de-Mesquita HB
Jansen E
van Duijnhoven FJ
Fedirko V
Rinaldi S
Romieu I
Riboli E
Romaguera D
Westphal S
Overvad K
Tjønneland A
Boutron-Ruault MC
Clavel-Chapelon F
Kaaks R
Lukanova A
Trichopoulou A
Lagiou P
Trichopoulos D
Agnoli C
Mattiello A
Saieva C
Vineis P
Tumino R
Peeters PH
Argüelles M
Bonet C
Sánchez MJ
Dorronsoro M
Huerta JM
Barricarte A
Palmqvist R
Hallmans G
Khaw KT
Wareham N
Allen NE
Crowe FL
Pischon T
Source :
Carcinogenesis [Carcinogenesis] 2012 Jun; Vol. 33 (6), pp. 1211-8. Date of Electronic Publication: 2012 Mar 19.
Publication Year :
2012

Abstract

Adiponectin-an adipose tissue-derived protein-may provide a molecular link between obesity and colorectal cancer (CRC), but evidence from large prospective studies is limited. In particular, no epidemiological study explored high-molecular weight (HMW) and non-HMW adiponectin fractions in relation to CRC risk, despite them being hypothesized to have differential biological activities, i.e. regulating insulin sensitivity (HMW adiponectin) versus inflammatory response (non-HMW adiponectin). In a prospective, nested case-control study, we investigated whether prediagnostic serum concentrations of total, HMW and non-HMW adiponectin are associated with risk of CRC, independent of obesity and other known CRC risk factors. A total of 1206 incident cases (755 colon and 451 rectal) were matched to 1206 controls using incidence-density sampling. In conditional logistic regression, adjusted for dietary and lifestyle factors, total adiponectin and non-HMW adiponectin concentrations were inversely associated with risk of CRC [relative risk (RR) comparing highest versus lowest quintile = 0.71, 95% confidence interval (CI) = 0.53-0.95, P(trend) = 0.03 for total adiponectin and RR = 0.45, 95% CI = 0.34-0.61, P(trend) < 0.0001 for non-HMW adiponectin]. HMW adiponectin concentrations were not associated with CRC risk (RR = 0.91, 95% CI = 0.68-1.22, P(trend) = 0.55). Non-HMW adiponectin was associated with CRC risk even after adjustment for body mass index and waist circumference (RR = 0.39, 95% CI = 0.26-0.60, P(trend) < 0.0001), whereas the association with total adiponectin was no longer significant (RR = 0.81, 95% CI = 0.60-1.09, P(trend) = 0.23). When stratified by cancer site, non-HMW adiponectin was inversely associated with both colon and rectal cancer. These findings suggest an important role of the relative proportion of non-HMW adiponectin in CRC pathogenesis. Future studies are warranted to confirm these results and to elucidate the underlying mechanisms.

Details

Language :
English
ISSN :
1460-2180
Volume :
33
Issue :
6
Database :
MEDLINE
Journal :
Carcinogenesis
Publication Type :
Academic Journal
Accession number :
22431719
Full Text :
https://doi.org/10.1093/carcin/bgs133